SG
Scott M. Giacobello
Chief Financial Officer

Scott M. Giacobello insider trades: Whitehawk Therapeutics (WHWK) stock buys and sales

Chief Financial Officer, Whitehawk Therapeutics Last trade Apr 16, 2026 23 Form 4 filings
$882K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2019
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 16, 2026WHWK↓ Sell$882K
Mar 3, 2025AADI↓ Sell$7K
Mar 13, 2020GWPH↑ Buy$49K
Mar 2, 2020GWPH↓ Sell$19K
Feb 26, 2020GWPH↓ Sell$35K
May 20, 2019GWPH↓ Sell$61K
Feb 26, 2019GWPH↓ Sell$65K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other WHWK insiders

Open-market trades in the last 12 months

About Scott M. Giacobello's insider trades

Scott M. Giacobello is Chief Financial Officer at Whitehawk Therapeutics (WHWK). Since Feb 26, 2019, Scott has reported 1 open-market purchase worth $49K and 6 sales worth $1.1M on SEC Form 4. In the last 12 months: 1 sale ($882K).

Their filings also include grants and awards (13 filings), option exercises (6 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WHWK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.